| For: | Goyal MK, Chowdhary R, Vohra C, Patel M, Kalra S, Mehta M, McNulty R, Goyal K, Vuthaluru AR, Goyal O. Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy. World J Hepatol 2026; 18(1): 115048 [PMID: 41640962 DOI: 10.4254/wjh.v18.i1.115048] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v18/i1/115048.htm |
| Number | Citing Articles |
| 1 |
Xiangyi Zhou, Hongbing Deng, Fachun Zhou, Zhihui Tong, Daqian Gu. Beyond the Muscle–Kidney Paradigm: Liver–Muscle–Kidney Interactions in Rhabdomyolysis. Life 2026; 16(11) doi: 10.3390/life16111852
|
| 2 |
Olga Sukocheva, Damian Harding, Tsai-Wing Ow, Edmund Tse. Sarcopenia and Skeletal Muscle Dysfunction in Liver Cirrhosis: Clinical Perspectives of Myostatin Inhibition. Biomedicines 2026; 14(9) doi: 10.3390/biomedicines14092082
|
| 3 |
Mahmut Sahin, Kemal Baris Sarici, Fatih Ahmet Ates, Nurullah Dag, Sami Akbulut. Longitudinal Changes in CT-Derived Vertebral Trabecular Attenuation and Psoas Muscle Density After Liver Transplantation for Hepatocellular Carcinoma. Medicina 2026; 62(10) doi: 10.3390/medicina62102044
|
| 4 |
Rishi Chowdhary, Manjeet Kumar Goyal, Megh Patel, Rahul Chowdhary, Kirti Arora, Varun Mehta, Akash Batta, Omesh Goyal, Ashita Rukmini Vuthaluru. Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease. Frontiers in Epidemiology 2026; 6 doi: 10.3389/fepid.2026.1779600
|